ReviewCurrent oncology reports2019
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.
Laura M Spring et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
88 papers cite itlatest 60 shown
this paperpooled ittrialcites it